Catalyst CEO and Founder Nancy Bradish Myers provided her perspective on FDA hybrid/telework policies and the impact of any potential changes in the future. With over 2,000 vacancies at the agency, a hiring push is under way, particularly given new funding provided under PDUFA VII for hiring in certain areas. The article highlights the positive impact the hybrid work environment has had on FDA morale in recent years, but that there is a House-led effort to require federal workers to return to in-person, pre-COVID work arrangements (and the Administration would like to see employees work in person more often). While the article cites a 2021 survey of FDA’s Centers showing that over a quarter of those staff would consider leaving the agency if they were permitted to work from home more often elsewhere, it also noted Ms. Myers’ view that “returning to the office may help the careers of young scientists who need mentorship that is difficult to provide over Zoom.”
Understanding the patient experience with CAR-T long-term follow-up (LTFU) is essential for building a sustainable model. Catalyst...
Scientific innovation in Cell & Gene Therapy (C>) is advancing rapidly, sparking hope for patients with rare diseases, cancer, and other debilitating conditions
Being rare is often a blessing: a rare gem stands out from a pile of stones, a rare talent can garner prestige and success, and a rare personality can make for an influential leader or a cultural icon.
On Tuesday, Catalyst’s Taryn Serman and Nancy Myers, together with industry leaders, published the following article regarding women’s health on LinkedIn.
March 14th is approaching fast, and it increasingly looks like politicians are driving us toward another government shutdown.